Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 5,540.00
+290.00 (5.52%)
At close: Jun 29, 2026
Wonbiogen Market Cap
Wonbiogen has a market cap or net worth of 37.78 billion as of June 29, 2026. Its market cap has decreased by -7.87% in one year.
Market Cap
37.78B
Enterprise Value
26.92B
Revenue
36.27B
Ranking
n/a
PE Ratio
5.55
Stock Price
5,540.00
Market Cap Chart
Since January 26, 2021, Wonbiogen's market cap has decreased from 47.59B to 37.78B, a decrease of -20.62%. That is a compound annual growth rate of -4.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 37.78B | -20.27% |
| Dec 30, 2025 | 47.38B | 16.35% |
| Dec 30, 2024 | 40.72B | -32.55% |
| Dec 28, 2023 | 60.37B | 3.39% |
| Dec 29, 2022 | 58.40B | -21.09% |
| Dec 30, 2021 | 74.00B | 55.49% |
| Jan 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DuChemBIO | 179.42B |
| JW Shinyak | 134.65B |
| CG MedTech | 128.04B |
| Sewoon Medical | 89.83B |
| OSTEONIC | 75.13B |
| SCL Science | 52.93B |
| MEDYSSEY Co.,Ltd | 41.70B |
| KM Corporation | 29.52B |